The International Partnership for Microbicides, has announced the initiation of the first clinical trial to test a vaginal microbicide containing DS003, a novel antiretroviral drug for the prevention of sexual transmission of HIV in women.
The study and trail which will take place in Belgium according to a statement by the IPM will evaluate the safety and tolerability of the ARV-based women’s![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
↧